# OnCo record paper-aaml1031-bortezomib-aplenc-haematologica-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aaml1031-bortezomib-aplenc-haematologica-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aaml1031-bortezomib-aplenc-haematologica-2020" ;
  schema:name "AAML1031: bortezomib with standard chemotherapy for children with acute myeloid leukaemia does not improve outcomes"@en ;
  schema:description "Adding the proteasome inhibitor bortezomib to standard chemotherapy for children with newly diagnosed acute myeloid leukaemia did not help them live longer or relapse less, and it caused more nerve damage and intensive care admissions."@en ;
  schema:url <https://onco.cc/key-papers/paper-aaml1031-bortezomib-aplenc-haematologica-2020/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.3324/haematol.2019.220962>, <https://pubmed.ncbi.nlm.nih.gov/32029509/> ;
  schema:sameAs <https://doi.org/10.3324/haematol.2019.220962> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Aplenc R, Meshinchi S, Sung L, et al." ;
  onco:cancers <https://onco.cc/cancers/aml-paediatric/>, <https://onco.cc/cancers/aml/> ;
  onco:drugs <https://onco.cc/drugs/bortezomib/> ;
  onco:trials <https://onco.cc/trials/aaml1031/> ;
  onco:journals <https://onco.cc/journals/haematologica/> .